Over 500 int'l patients receive cancer care at HMC in 2024

Hamad Medical Corporation’s National Center for Cancer Care and Research (NCCCR) has provided treatment for more than 500 international cancer patients in 2024, making it one of the most sought after destinations for cancer treatment in the region.

NCCCR has become a leading destination for cancer treatment in the Gulf, attracting patients from across the region while continuing to provide world-class care to Qatar’s local population. With advanced technology, personalised treatment plans, and a highly skilled multidisciplinary team, NCCCR continues to set the benchmark for oncology services.

Dr Mohamed Salem al-Hassan, medical director and CEO of NCCCR and chair of Corporate Cancer Services at HMC, highlighted the hospital’s growing international reputation: “In 2024, we treated 508 international patients from the region. NCCCR is recognised across the region for its exceptional quality of care and innovative treatments. Patients come to us not only for access to cutting-edge therapies and state-of-the-art facilities but also because of our holistic, patient-centred approach. Our unique combination of expertise, highly advanced technology, and compassionate care has made us the preferred choice for many patients from the GCC and beyond.”

He said, “HMC is a leader in cancer care, offering treatment options that are often unavailable elsewhere in the region. From robotic-assisted surgery to precision medicine and breakthrough target hormone and immunotherapies, our capabilities ensure the best possible outcomes for our patients. While we are honoured to welcome patients from neighbouring countries seeking specialised care, our foremost commitment remains to the people of Qatar, ensuring they receive the highest standard of cancer treatment without the need to travel abroad.”

NCCCR provides a full spectrum of cancer care, including Bone Marrow Transplants, cutting-edge Radiation Oncology using technologies like TrueBeam, ETHOS, and CyberKnife, and comprehensive genetic counselling to assess hereditary cancer risks. The centre also prioritises mental health, offering psychotherapy services to support patients throughout their treatment journey.

As a regional leader in oncology, NCCCR is dedicated to advancing cancer care through innovation, research, and continuous improvements, ensuring that both Qatar’s local population and international patients receive the highest standard of treatment available in the region.